Raymond James Maintains Outperform on Insulet, Lowers Price Target to $228

Benzinga · 09/15/2023 11:45
Raymond James analyst Jayson Bedford maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the price target from $299 to $228.